ONCR || FDA & CDC

Lenvima gets the FDA’s nod for differentiated thyroid cancer

Posted on: 13/02/2015 - 17:23

The Food and Drug Administration has approved the kinase inhibitor lenvatinib (Lenvima) for the treatment of differentiated thyroid cancer, the agency... More »

Field of Interest: Oncology

Type: News Item

FDA approves palbociclib with letrozole for advanced postmenopausal breast cancer

Posted on: 03/02/2015 - 23:53

Palbociclib, a cyclin-dependent kinase 4/6 inhibitor, has been approved by the Food and Drug Administration for treating postmenopausal women with est... More »

Field of Interest: Pulmonology

Type: News Item

FDA approves palbociclib with letrozole for advanced postmenopausal breast cancer

Posted on: 03/02/2015 - 23:53

Palbociclib, a cyclin-dependent kinase 4/6 inhibitor, has been approved by the Food and Drug Administration for treating postmenopausal women with est... More »

Field of Interest: Oncology

Type: News Item

FDA panel votes against panobinostat as add-on therapy for multiple myeloma

Posted on: 07/11/2014 - 11:34

SILVER SPRING, MD. – The majority of a Food and Drug Administration advisory panel agreed that the risk-benefit profile of panobinostat as add-on treatment to bortezomib and dexamethasone did not...

Field of Interest: Oncology

Type: News Item

CDC: More can be done to prevent cervical cancer fatalities

Posted on: 05/11/2014 - 19:54

Close to 8 million women aged 21-65 years were not screened for cervical cancer in the past 5 years even though the disease claims nearly 4,000 lives per year, according to 2012 data, the Centers for...

Field of Interest: Pulmonology

Type: News Item

CDC: More can be done to prevent cervical cancer fatalities

Posted on: 05/11/2014 - 19:54

Field of Interest: Oncology

Type: News Item

FDA advisers want more data on sunscreen safety

Posted on: 05/09/2014 - 20:40

SILVER SPRING, MD. – The widespread and long-term use of sunscreens demands that manufacturers provide more long-term safety data and information on how the active ingredients affect the health of...

Field of Interest: Oncology

Type: News Item

FDA advisers want more data on sunscreen safety

Posted on: 05/09/2014 - 20:40

Field of Interest: Dermatology

Type: News Item

ASCO and AACR call for stronger e-cigarette regulation

Posted on: 14/08/2014 - 22:05

A Food and Drug Administration proposal to regulate e-cigarettes does not go far enough, the American Society of Clinical Oncology and the American Association for Cancer Research say. The two...

Field of Interest: Oncology

Type: News Item

Approval of mercaptopurine suspension will facilitate pediatric dosing

Posted on: 29/04/2014 - 18:30

More than 60 years after it first became available as a 50-mg tablet, an oral suspension formulation of mercaptopurine has been approved by the Food and Drug Administration. The oral suspension...

Field of Interest: Oncology

Type: News Item

Lenvima gets the FDA’s nod for differentiated thyroid cancer

FDA approves palbociclib with letrozole for advanced postmenopausal breast cancer

FDA approves palbociclib with letrozole for advanced postmenopausal breast cancer

FDA panel votes against panobinostat as add-on therapy for multiple myeloma

CDC: More can be done to prevent cervical cancer fatalities

CDC: More can be done to prevent cervical cancer fatalities

FDA advisers want more data on sunscreen safety

FDA advisers want more data on sunscreen safety

ASCO and AACR call for stronger e-cigarette regulation

Approval of mercaptopurine suspension will facilitate pediatric dosing

Newsletters

Latest Newsletters

You are here

ONCR || FDA & CDC

Newsletters

Latest Newsletters